Trials / Recruiting
RecruitingNCT06785337
"The Effect of Inhaled Nitroglycerin for COPD Patients
"The Effect of Inhaled Nitroglycerin on Improving Respiratory Failure in COPD Patients Admitted to Adult Intensive Care Unit"
- Status
- Recruiting
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Beni-Suef University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
this study aims to investigative the benefits of using nebulized nitroglycerin in improving respiratory functions in patients of late stage COPD
Detailed description
the inhaled nitroglycerin is expected to make vasodilatation of the pulmonary arteries and arterioles which are constricted in late stages of COBD leading to ventilation/perfusion mismatching and further aggravating COPD. it will also help in delivering better antibiotic concentrations to the alveoli which help in better control of infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Inhaled nitroglycerin | Inhaled nitroglycerin |
Timeline
- Start date
- 2025-02-01
- Primary completion
- 2025-10-01
- Completion
- 2025-12-01
- First posted
- 2025-01-21
- Last updated
- 2025-01-23
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06785337. Inclusion in this directory is not an endorsement.